PTC Therapeutics proposes $500 million convertible notes offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
June 15, 2026 7:00 AM EDTProceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity
Offering to include buyback of common stock
WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate... More



